The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,778.00
Bid: 1,774.00
Ask: 1,774.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.028%)
Open: 1,796.00
High: 0.00
Low: 0.00
Prev. Close: 1,778.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-FTSE 100 reverses course to end lower on Imperial slump

Thu, 20th Feb 2020 09:32

* FTSE 100 down 0.3%, FTSE 250 up 0.1%

* Ex-dividend trading drags down main bourse

* Smith+Nephew, Moneysupermarket.com among notable gainers

* Virus cases in South Korea deter more rapid gains
(Recasts with market reversing course, updates share prices
throughout)

By Shashwat Awasthi and Muvija M

Feb 20 (Reuters) - London's FTSE 100 handed back earlier
gains to record losses on Thursday as a 7.3% fall in tobacco
giant Imperial Brands overshadowed a 10% leap in medical
products maker Smith+Nephew.

The blue-chip index slipped 0.3% as Imperial Brands
tumbled on ex-dividend trading, while most other sectors
also traded in the red with a surge in coronavirus infections in
South Korea stoking fears about a deepening health crisis.

Smith+Nephew hit an all-time high and helped limit
losses on the index after the medical products maker forecast
another year of revenue growth.

The FTSE 250 midcap index ended the day with a 0.1%
rise, led by a 19% surge in price comparison website
Moneysupermarket.com following upbeat outlook and a 7%
jump in engineering firm Spectris after 2019 results.

For the most part, the British indexes have drawn support
this week from stimulus measures from China, which cut its
benchmark lending rate to cushion the impact of the coronavirus
epidemic.

Both indexes are headed for a week of gains.

"Investors are making a number of significant assumptions
that governments and central banks will be able to mitigate the
effects of any disruption in the short and medium term," CMC
Markets analyst Michael Hewson said.

"Time will tell whether that is a safe assumption to make,
however in the absence of anywhere else to put one's money, the
line of least resistance for now appears to be to buy stocks."

Among other notable gainers on the main index were defence
firm BAE Systems and lender Lloyds with gains
of 3% and 1.4%, respectively, after their annual results.

However, the FTSE 100's losses were deepened by 1%-1.7%
falls in GlaxoSmithKline and Unilever, whose
stocks also traded without dividend entitlement.

Small-cap bathroom and kitchen products supplier Norcros
slid 11% after it warned annual profit would miss market
expectations and supply chain disruptions due to the coronavirus
outbreak would likely hit performance.
(Reporting by Shashwat Awasthi in Bengaluru; Editing by Shounak
Dasgupta, Saumyadeb Chakrabarty and Alison Williams)

More News
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.